U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382661) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and Amoxicillin/Clarithromycin' on Jan. 27.
Brief Summary: Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Volunteers
Intervention:
DRUG: DW4421
1 tablet will be orally administered
DRUG: DW4421-1
2 capsules will be orally administered
DRUG: DW4421-2
1 tablet will be orally administered
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewon Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....